Skip to main content

Advertisement

Log in

Does the early adopter of drugs exist? A population-based study of general practitioners’ prescribing of new drugs

  • Pharmacoepidemiology and Prescription
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

An Erratum to this article was published on 04 February 2005

Abstract

Objective

To analyse associations between indicators for adoption of new drugs and to test the hypothesis that physicians’ early adoption of new drugs is a personal trait independent of drug groups.

Methods

In a population-based cohort study using register data, we analysed the prescribing of new drugs by Danish general practitioners. Angiotensin-II antagonists, triptans, selective cyclo-oxygenase-2 antagonists and esomeprazol were used in the assessment. As indicators of new drug uptake, we used adoption time, cumulative incidence, preference proportion, incidence rate and prescription cost and volume. For each measure, we ranked the general practices. Ranks were pair-wise plotted, and Pearson’s correlation coefficient (r) was calculated. Next, we analysed the correlation between ranks across different drug classes.

Results

For all indicators, the general practitioners’ adoption of one group of drugs was poorly associated with adoption of others (r≤0.49), indicating that early adoption of one type of drugs is not associated with early adoption of another. For all drug groups, adoption time adjusted for practice size was only weakly associated with other indicators (r: −0.56 to −0.27). Indicators, based on cost and volume of drugs, were highly correlated (r: 0.96–0.99), and the others correlated reasonably well (r: 0.51–0.91).

Conclusions

Within drug groups, indicators of drug adoption, except for adoption time, correlate reasonably well. However, the theory that physicians’ early adoption of new drugs is a personal trait independent of the type of drug could not be confirmed. The notion of the early-drug-adopting general practitioner may be mistaken.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Department of Health (2003) Delivering the NHS plan—expenditure report. Department of Health publications, London

    Google Scholar 

  2. The National Institute for Health Care Management Research and Educational Foundation (2001) Prescription drug expenditure 2000: the upward trend continues. The Institute, Washington, DC

    Google Scholar 

  3. The National Institute for Health Care Management Research and Educational Foundation (2002) Changing patterns of pharmaceutical innovation. The Institute, Washington DC

    Google Scholar 

  4. Pearson SA, Ross-Degnan D, Payson A, Soumerai SB (2003) Changing medication use in managed care: a critical review of the available evidence. Am J Manag Care 9(11):715–731

    PubMed  Google Scholar 

  5. NHS Centre for Reviews and Dissemination (1999) Getting evidence into practice. Effective Health Care, University of York, York

    Google Scholar 

  6. Granados A, Jonsson E, Banta HD, Bero L, Bonair A, Cochet C et al (1997) EUR-ASSESS project subgroup report on dissemination and impact. Int J Technol Assess Health Care 13(2):220–286

    CAS  Google Scholar 

  7. Rogers EM (1995) Diffusion of innovations. The Free Press, New York

    Google Scholar 

  8. Coleman JS, Katz E, Menzel H (1966) Medical innovation: a diffusion study. The Bobbs-Merrill Co., Indianapolis

    Google Scholar 

  9. Lomas J (1994) Teaching old (and not so old) Docs new tricks: effective ways to implement research findings. In: Dunn EV et al (eds) Disseminating new knowledge and having an impact on practice. Sage Publication, Newbury Park

    Google Scholar 

  10. Haines A, Donald A (1998) Making better use of research findings. BMJ 317:72–75

    CAS  PubMed  Google Scholar 

  11. Groves KEM, Fanagan PS, MacKinnon NJ (2002) Why physicians start or stop prescribing a drug: literature review and formulary implications. Formulary 37:186–194

    Google Scholar 

  12. DeCherney GS (1999) Accelerating acceptance. Physician Exec 25:32–38

    CAS  Google Scholar 

  13. Moulding NT, Silagy CA, Weller DP (1999) A framework for effective management of change in clinical practice: dissemination and implementation of clinical practice guidelines. Qual Health Care 8:177–183

    CAS  PubMed  Google Scholar 

  14. Steffensen FH, Sorensen HT, Olesen F (1999) Diffusion of new drugs in Danish general practice. Fam Pract 16:407–413

    Article  CAS  PubMed  Google Scholar 

  15. Gaist D, Sorensen HT, Hallas J (1997) The Danish prescription registries. Dan Med Bull 44:445–448

    CAS  PubMed  Google Scholar 

  16. WHO Collaborating Centre for Drug Statistics Methodology (2002) Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre, Oslo

    Google Scholar 

  17. Hosmer DW, Lemeshow S (1999) Applied survival analysis: regression modelling of time to event data. Wiley, New York

    Google Scholar 

  18. Sondergaard J, Andersen M, Vach K, Kragsrup J, Maclure M, Gram LF (2002) Detailed postal feedback about prescribing to asthma patients combined with a guideline statement showed no impact: a randomised controlled trial. Eur J Clin Pharmacol 58:127–132

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Torben Dybdahl.

Additional information

An erratum to this article can be found at http://dx.doi.org/10.1007/s00228-005-0899-4

Rights and permissions

Reprints and permissions

About this article

Cite this article

Dybdahl, T., Andersen, M., Søndergaard, J. et al. Does the early adopter of drugs exist? A population-based study of general practitioners’ prescribing of new drugs. Eur J Clin Pharmacol 60, 667–672 (2004). https://doi.org/10.1007/s00228-004-0797-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00228-004-0797-1

Keywords

Navigation